Denosumab (Prolia®) for the treatment of osteoporosis
Moshi M, Nicolopoulos K, Stringer D, Gaget V, Ma N, Vreugdenburg T
Record ID 32018001645
English
Details
Project Status:
Completed
URL for project:
https://www.bag.admin.ch/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/denosumab.html
Year Published:
2022
URL for published report:
https://www.bag.admin.ch/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/denosumab.html
URL for additional information:
https://www.bag.admin.ch/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-programm.html
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Switzerland
MeSH Terms
- Osteoporosis
- Osteoporosis, Postmenopausal
- Denosumab
- Bone Density Conservation Agents
- Diphosphonates
- Selective Estrogen Receptor Modulators
Keywords
- osteoporosis
- denosumab
- bisphosphonates
- selective oestrogen receptor modulators
- PROMs
- efficacy
- effectiveness
- safety
- costs
- economics
- cost-effectiveness
- budget impact
- legal
- social
- ethical
- organisational
Contact
Organisation Name:
Swiss Federal Office of Public Health (FOPH)
Contact Address:
Federal Office of Public Health, Schwarzenburgstrasse 157, CH-3003 Berne, Switzerland
Contact Name:
Stephanie Vollenweider
Contact Email:
hta@bag.admin.ch
Copyright:
Swiss Federal Office of Public Health
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.